Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracaine mucilage plus intravenous anesthesia vs intravenous anesthesia alone for painless cystoscopy
ChiCTR2300070527Phase 4Not yet recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tetracaine in urinary tract infection (UTI) and Presence of ureteral stent (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: Intravenous anesthesia drug (propofol) dosage. Planned start May 2023; status: not yet recruiting.
02
Drugs
tetracaine
03
Conditions
urinary tract infection (UTI)Presence of ureteral stent
Beyond the preview
Go deeper on ChiCTR2300070527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070527.